論文・技術情報追加のお知らせ

1. Central nervous system hemorrhage related to protein kinase inhibitors: A real-world pharmacovigilance case-control study and genetic correlation study.

プロテインキナーゼ阻害薬関連の中枢神経系出血の解析。

対象DB：FAERS

2. Adverse event signals associated with targeted therapy plus chemotherapy in colorectal cancer: A FAERS-based pharmacovigilance study.

大腸がん分子標的薬と化学療法併用の有害事象シグナル解析。

対象DB：FAERS

3. Drugs Associated with Dementia-Related Adverse Event Reports: A Real World Pharmacovigilance Study.

実臨床データに基づく認知症関連副作用報告と関連薬剤の解析。

対象DB：FAERS

4. Disproportionality analysis of ventricular extrasystoles reported with semaglutide in VigiBase and the FDA Adverse Event Monitoring System.

セマグチド投与に伴う心室性期外収縮の多国籍不均衡分析。

対象DB：FAERS,VigiBase

5. Potential association between IL-12/23, IL-23, and IL-17 inhibitors and skin cancer: a pharmacovigilance study based on the FAERS database.

IL阻害薬と皮膚がんリスクの関連に関するFAERS解析。

対象DB：FAERS

6. Bullous Pemphigoid Associated With Psychotropic Medications.

向精神薬使用に関連する類天疱瘡発症リスクに関する考察。

対象DB：FAERS

7. Safety profile of desmopressin and risk signals for hyponatremia: evidence from FAERS and CVARDD real-world databases.

デスモプレシン関連低ナトリウム血症の自発報告安全性解析。

対象DB：CVAR,FAERS

8. A disproportionality analysis of adverse event reports for givinostat in the FDA adverse event reporting system (FAERS) database.

デュシェンヌ型筋ジス薬ギビノスタットのFAERS解析。

対象DB：FAERS

9. Glucocorticoid-centered drug spectrum of non-jaw osteonecrosis, a FAERS pharmacovigilance study with independent validation in Canada Vigilance and JADER.

非顎骨壊死におけるグルココルチコイド中心の薬剤シグナル。

対象DB：CVAR,FAERS,JADER

10. Abacavir-Containing Versus Abacavir-Free Dolutegravir-Based Regimens: A Cardiovascular Pharmacovigilance Analysis.

HIV治療におけるアバカビル含有療法の心血管安全性評価。

対象DB：FAERS

11. Psychiatric and Behavioral Adverse Event Reporting Patterns Among Dopamine Agonists in Parkinson's Disease Using the Food and Drug Administration Adverse Event Reporting System.

パーキンソン病ドパミン作動薬の精神・行動副作用解析。

対象DB：FAERS

12. Real-world safety profile of finerenone in patients with type 2 diabetes and chronic kidney disease: a multi-database pharmacovigilance analysis of the FAERS and JADER systems.

糖尿病性腎臓病患者でのフィネレノンの市販後安全性解析。

対象DB：FAERS,JADER

13. Gastrointestinal safety signals of Janus kinase inhibitors: a real-world pharmacovigilance study using Food and Drug Administration Adverse Event Reporting System.

皮膚科領域におけるJAK阻害薬の消化器系安全性解析。

対象DB：FAERS

14. INDIVIDUAL ARTICLE: Real-World Study of Topical Corticosteroid-Associated Adverse Events in the FDA Adverse Event Reporting System.

外用副腎皮質ステロイド関連有害事象のFAERS解析。

対象DB：FAERS

15. Epidemiological Characteristics and Clinical Outcomes of Vaccine-associated Urticaria: A Retrospective Cross-sectional Analysis of the Vaccine Adverse Event Reporting System Database (1990-2025).

ワクチン接種後蕁麻疹の疫学的特徴と転帰に関する調査。

対象DB：FAERS,VAERS

16. Exploring ifosfamide-related central nervous system adverse events based on the FAERS database and clinical feature analysis of cases.

イホスファミド誘発性中枢神経系有害事象の臨床特徴解析。

対象DB：FAERS

17. Drugs associated with severe anaphylaxis in children and adolescents: a real-word FAERS pharmacovigilance study.

小児・思春期における重症アナフィラキシー誘発薬の解析。

対象DB：FAERS

18. Signals, not verdicts: interpreting pediatric anaphylaxis reports from the FDA Adverse Event Reporting System.

FAERS小児アナフィラキシー報告の解釈に関する考察。

対象DB：FAERS

19. Respiratory adverse-event signals of four Bruton tyrosine kinase inhibitors: cross-database replication and temporal characterization in FAERS and JADER.

BTK阻害薬4種における呼吸器系有害事象の二国間DB解析。

対象DB：JADER

20. Cutaneous adverse events of Bruton tyrosine kinase inhibitors in FAERS, Canada Vigilance, JADER and VigiMed: a multi-database pharmacovigilance study.

4つの自発報告DBを用いたBTK阻害薬の皮膚副作用解析。

対象DB：CVAR,JADER

21. Real-world pharmacovigilance of intra-articular triamcinolone acetonide in arthritis treatment: a two-decade FAERS and JADER study with machine learning prediction and SHAP-based interpretation.

トリアムシノロン関節内投与の安全性と機械学習予測モデル。

対象DB：JADER

22. Suspected adverse drug reaction reports in sheep and goats in the EudraVigilance veterinary database: Analysis of reporting patterns for selected veterinary medicinal products.

欧州獣医自発報告DBにおけるヒツジ・ヤギの副作用解析。

対象DB：EudraVigilance

23. Signal of venous thromboembolism with ethinyl estradiol vs natural estrogens in oral contraceptives: analysis of the EudraVigilance and Food and Drug Administration Adverse Events Reporting System databases.

経口避妊薬における合成対天然エストロゲンの血栓症リスク。

対象DB：EudraVigilance

24. A Retrospective Pharmacovigilance Study of Carmustine Using VigiBase: Safety Implications for Section 21 Access in South Africa.

カルムスチンの安全性に関するVigiBase不均衡分析。

対象DB：VigiBase

25. Postoperative Day 0 Restraint and Prolonged Use in Older Colectomy Patients Receiving Dementia Care.

結腸切除術高齢患者における術当日身体拘束と長期拘束解析。

対象DB：DPC

26. Risk of deep vein thrombosis and pulmonary embolism after simultaneous bilateral knee arthroplasty: A Japanese nationwide medical claims database study.

同時両側人工膝関節置換術後の深部静脈血栓・肺塞栓リスク。

対象DB：DPC

27. Effect of stress ulcer prophylaxis on gastrointestinal bleeding after severe burns: A nationwide retrospective cohort study.

重症熱傷患者におけるストレス潰瘍予防薬と消化管出血予防。

対象DB：DPC

28. Age-Specific Temporal Trends and Climate-Associated Seasonality of Appendectomy in Japan: A Nationwide Population-Based Study Using the National Database.

日本における虫垂切除術の年齢別傾向と気候関連季節性解析。

対象DB：NDB

29. Nationwide real-world data on tumor-agnostic genomic companion diagnostics and comprehensive genomic profiling tests.

がんゲノムプロファイリング検査とコンパニオン診断の実態。

対象DB：MDV

30. Antipsychotic Doses in Patients With Tardive Dyskinesia Who Received Valbenazine: A Retrospective Study Using Japanese Claims Data.

バルベナジン投与遅発性ジスキネジア患者の抗精神病薬用量。

対象DB：MDV

31. Patterns and potential indications of WHO AWaRe Watch antibiotic use across UK community and hospital care: a national observational study.

英国におけるWHO Watch分類抗菌薬の使用パターン調査。

対象DB：CPRD

32. Cardiovascular Events Among Female Users of Osteoporosis Treatments: A Cohort Study in United Kingdom Primary Care Data.

女性骨粗鬆症治療薬使用患者における心血管イベント評価。

対象DB：CPRD

33. Are non-cancer diagnoses missed opportunities in diagnosing cancer? Observational case-control studies.

がん診断前の非がん診断による診断機会喪失に関する調査。

対象DB：CPRD

34. Efficacy and safety of statin discontinuation in patients 65 years and older according to frailty status: a population-wide retrospective cohort study in England using Clinical Practice Research Datalink data.

65歳以上高齢者におけるフレイル状態別スタチン中止の影響。

対象DB：CPRD

35. Patient-centred workload clustering in adults under 65 with long-term conditions from longitudinal primary care data.

65歳未満の慢性疾患患者における患者負担クラスタリング。

対象DB：CPRD

36. Treatment status of iron medications for anemia in patients visiting gynecological or obstetric facilities: analyses using Japanese claims data.

産婦人科を受診した貧血患者における鉄剤処方の実態調査。

対象DB：DeSC

37. Changes in Health Literacy and Subsequent Presenteeism Among Workers: A Repeated-Measures Longitudinal Database Study.

労働者のヘルスリテラシー変化とプレゼンティーズムの関連。

対象DB：DeSC

38. Deep learning-based prediction of insect odorant receptor-ligand interactions for behavioral regulator discovery.

深層学習を用いた昆虫嗅覚受容体リガンド相互作用の予測。

対象DB：DeSC